Figure 1.

Model-adjusted mean difference in ABPM for rosiglitazone compared to sulfonylurea and to metformin in combination therapy.

Komajda et al. Cardiovascular Diabetology 2008 7:10   doi:10.1186/1475-2840-7-10
Download authors' original image